| 2018-03-20 07:15:48|
HQY 07:15 03/20 03/20/18
HealthEquity price target raised to $70 from $60 at SunTrust
SunTrust analyst Sandy Draper raised his price target on HealthEquity to $70 after the company's Q4 earnings beat and raised FY19 outlook. Draper notes that while there is limited upside opportunity for revenue in the current fiscal year due to "seasonality of open enrollment", his bullish view is driven by the company's "market share grabbing and margin-expanding revenue growth" over the longer term within a positive market environment. The analyst keeps his Buy rating on HealthEquity.